Picture of Janux Therapeutics logo

JANX — Janux Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: Janux Therapeutics Q3 Basic EPS USD -0.39

Nov 06 (Reuters) - Janux Therapeutics Q3 net income USD -24.313 million.

Q3 collaboration revenue USD 10 million

Q3 operating expenses USD 45.251 million

Q3 operating income USD -35.251 million

Recent news on Janux Therapeutics

See all news